Yahoo! Finance: Top Stories

Jazz Pharmaceuticals Releases Unexpected Phase 4 Results Highlighting Xywav®

Jun 13, 2025 - 10:36
 0
Jazz Pharmaceuticals Releases Unexpected Phase 4 Results Highlighting Xywav®
Read More

Tags:

Previous Article

JPMorgan Calls the Selloff Excessive, Trims Regeneron Pharmaceuticals, Inc. (REG...

Next Article

Axsome’s AXS-14 Gets Regulatory Setback with RTF, says Morgan Stanley

Related Posts

Dollar Weakens as U.S. Indicators Show Weakness

Dollar Weakens as U.S. Indicators Show Weakness

May 29, 2025  0

Bonnell: France Is a 'Good Deal' to Do Investment

Bonnell: France Is a 'Good Deal' to Do Investment

May 21, 2025  0

Ivanhoe Mines to restart western section of Kakula Mine

Ivanhoe Mines to restart western section of Kakula Mine

Jun 3, 2025  0